Search Results 331-340 of 16542 for Tofu

  1. Firat Kara, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic's Firat Kara, Ph.D., researches neuroimaging in aging and dementia, women's brain health in neurodegenerative diseases, and sex differences and ...

  2. Long-term Safety And Tolerability Of Atacicept (Long-term Follow-Up Of Patients Who Participated In ADDRESS II) - Mayo Clinic

    About this study. This is a multicenter, double-blind, Phase 2b, long-term extension (LTE) to the ADDRESS II core trial (EMR 700461-023) (NCT01972568), ...

  3. A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment - Mayo Clinic

    A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously ...

  4. Mayo Clinic Radio Health Minute July 2018

    Mayo Clinic Radio Health Minute. July 2018. Jul. 2nd. Healthy farmers market finds. Jul. 3rd. Pediatric asthma risk factors. Jul. 4th. E Coli facts.

  5. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Long Term Follow Up of Mammography Screening - Mayo Clinic

    The purpose of this study is to execute a long-term retrospective observational cohort study of women who underwent screening mammography (defined as digital ...

  7. A Study Of The Characteristics And Outcomes Of Treatment For C. Diff In Post-Transplant Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Pembrolizumab has been approved for treatment of patients with melanoma but has not been proven to be safe or helpful in patients with pancreatic cancer and is ...

  9. Tobias Kohler, M.D. - Mayo Clinic

    National Doctors' Day is March 30! Give Now! Your gift to celebrate this day advances our doctors' lifesaving work. Give Now!

  10. Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...